(RTTNews) - scPharmaceuticals Inc. (SCPH) Monday reported positive topline results from the pharmacokinetic study of SCP-111 (furosemide), administered via an autoinjector. The study compared the ...
The autoinjector is being developed to deliver a subcutaneous injection of furosemide as an alternative option to the FDA approved FUROSCIX on-body infusor presentation Company targeting Supplemental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results